PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification by Parodis, I, Liefaard, L, Green, Y, Gilbride, JA, Henning, C, Levy, RA, Dimelow, R

Get full text

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis by Richards, Duncan B, Cookson, Louise M, Barton, Sharon V, Liefaard, Lia, Lane, Thirusha, Hutt, David F, Ritter, James M, Fontana, Marianna, Moon, James C, Gillmore, Julian D, Wechalekar, Ashutosh, Hawkins, Philip N, Pepys, Mark B

Get full text

P449 Selective depletion of LAG3+ cells in T-cell-driven inflammation: a randomised, double-blind, placebo-controlled, FTIH phase I/Ib clinical trial by Ellis, J, Marks, D, Barrett, C, Hopkins, T, Richards, A, Fuhr, R, Albayaty, M, Coenen, M, Liefaard, L, Leavens, K, Nevin, K, Tang, S, Hughes, S, Srinivasan, N, Edwards, K, Anselm, R, Schmidt, T, Stone, J, Savage, C, Wisniacki, N, Tarzi, R

Get full text

Population Pharmacokinetic Modeling of Tapentadol Extended Release (ER) in Healthy Subjects and Patients with Moderate or Severe Chronic Pain by Huntjens, Dymphy R., Liefaard, Lia C., Nandy, Partha, Drenth, Henk-Jan, Vermeulen, An

Get full text

Population Pharmacokinetic Analysis for Simultaneous Determination of B max and K D In Vivo by Positron Emission Tomography by Liefaard, Lia C., Ploeger, Bart A., Molthoff, Carla F. M., Boellaard, Ronald, Lammertsma, Adriaan A., Danhof, Meindert, Voskuyl, Rob A.

Get full text

Population Pharmacokinetic Analysis for Simultaneous Determination of B sub(max) and K sub(D) In Vivo by Positron Emission Tomography by Liefaard, L C, Ploeger, BA, Molthoff, CFM, Boellaard, R, Lammertsma, A A, Danhof, M, Voskuyl, R A

Get full text

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer by Liefaard, M C, van der Voort, A, van Ramshorst, M S, Sanders, J, Vonk, S, Horlings, H M, Siesling, S, de Munck, L, van Leeuwen, A E, Kleijn, M, Mittempergher, L, Kuilman, M M, Glas, A M, Wesseling, J, Lips, E H, Sonke, G S

Get full text

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade by Liefaard, M. C., van der Voort, A., van Seijen, M., Thijssen, B., Sanders, J., Vonk, S., Mittempergher, L., Bhaskaran, R., de Munck, L., van Leeuwen-Stok, A. E., Salgado, R., Horlings, H. M., Lips, E. H., Sonke, G. S.

Get full text

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies by Debets, Donna O., de Graaf, Erik L., Liefaard, Marte C., Sonke, Gabe S., Lips, Esther H., Ressa, Anna, Altelaar, Maarten

Get full text

Depletion of LAG‐3+ T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781 by Ellis, Joanne, J.B. Marks, Daniel, Srinivasan, Naren, Barrett, Christine, Hopkins, Thomas G., Richards, Anna, Fuhr, Rainard, Albayaty, Muna, Coenen, Martin, Liefaard, Lia, Leavens, Karen, Nevin, Katherine L., Tang, Shuo, Hughes, Stephen A., Fortunato, Léa, Edwards, Ken, Cui, Yi, Anselm, Rabia, Delves, Christopher J., Charles, Emilie, Feeney, Maria, Webb, Thomas M., Brett, Sara J., Schmidt, Tim S., Stone, John, Savage, Caroline O.S., Wisniacki, Nicolas, Tarzi, Ruth M.

Get full text